Maintenance Notice (12:30 AM - 5:30 AM August 24, 2025): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase and was first isolated from rabbit skeletal muscle.1) There are two isoforms of mammalian GSK-3, including GSK-3α and GSK-3β, which are encoding by separate genes (GSK3A, GSK3B).2) GSK-3 is associated with various signaling pathways including the wnt/β-catenin pathway.3)
A large number of GSK-3 inhibitors have been reported and classified into two types, ATP-competitive and non-ATP-competitive inhibitors.4) TDZD-8 (Thiadiazolidine-8, 1) is a non-ATP-competitive inhibitor of GSK-3β (Study I in the Table).5) Interestingly, in the study using PKC isoforms, it is shown that PKCβ 1, PKCδ, and PKCι are also inhibited by 1 (Study II in the Table).6)
The product is for research purpose only.
References
1)Glycogen synthase kinase-3 from rabbit skeletal muscle, separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase
5)First non-ATP competitive glycogen synthase kinase 3β (GSK-3β) inhibitors: Thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer’s disease
6)Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8)
The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order. In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.